[Controversies and future of the approach to cardiovascular disease in HIV patients]

Enferm Infecc Microbiol Clin. 2009 Sep:27 Suppl 1:48-53. doi: 10.1016/S0213-005X(09)73445-7.
[Article in Spanish]

Abstract

Cardiovascular diseases are an increasing problem in patients with HIV infection. The causes of the increased cardiovascular risk in HIV-infected patients are multifactorial. Currently, the question of which factor has the most weight in this equation - whether traditional risk factors, the virus per se or antiretroviral therapy - remains to be determined. The absolute risk of cardiovascular disease in a particular patient depends on the composite risk profile. At present, there are no data to support a distinct approach to cardiovascular risk evaluation in HIV-infected patients. Cardiovascular risk equations should be incorporated into routine daily clinical assessment in order to identify patients in need of specific interventions.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Adult
  • Aged
  • Anti-HIV Agents / adverse effects
  • Anti-HIV Agents / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use
  • Antiretroviral Therapy, Highly Active
  • Arteriosclerosis / epidemiology
  • Arteriosclerosis / etiology
  • Cardiovascular Diseases / epidemiology*
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / prevention & control
  • Cohort Studies
  • Comorbidity
  • Cytokines / metabolism
  • Disease Susceptibility
  • Forecasting
  • HIV Infections / epidemiology*
  • Humans
  • Hyperlipidemias / chemically induced
  • Hyperlipidemias / epidemiology
  • Inflammation / drug therapy
  • Inflammation / epidemiology
  • Insulin Resistance
  • Middle Aged
  • Prevalence
  • Prospective Studies
  • Retrospective Studies
  • Risk Factors

Substances

  • Anti-HIV Agents
  • Anti-Inflammatory Agents, Non-Steroidal
  • Cytokines